Hypocalcaemia may reduce the beneficial effect of magnesium treatment in aneurysmal subarachnoid haemorrhage.

  title={Hypocalcaemia may reduce the beneficial effect of magnesium treatment in aneurysmal subarachnoid haemorrhage.},
  author={Jolanda M W van de Water and Walter M van den Bergh and Reinier G. Hoff and Ale Algra and Gabriel J E Rinkel},
  journal={Magnesium research},
  volume={20 2},
To assess whether magnesium treatment in patients with subarachnoid haemorrhage (SAH) is associated with hypocalcaemia and whether hypocalcaemia in these patients is associated with an increased risk of delayed cerebral ischemia (DCI) and poor outcome. All 137 patients randomized in the clinically controlled "Magnesium in Aneurysmal Subarachnoid Haemorrhage" trial were included. The relationship between mean serum magnesium and mean serum calcium during treatment was assessed with linear… 
Calcium Homeostasis During Magnesium Treatment in Aneurysmal Subarachnoid Hemorrhage
Magnesium treatment in patients with SAH leads to hypocalcemia without effect on outcome, and PTH is related to poor outcome, but this is independent of magnesium therapy.
Magnesium sulphate in the management of patients with aneurysmal subarachnoid haemorrhage: A meta-analysis of prospective controlled trials
The meta-analysis suggests that intravenous magnesium therapy reduces the risk of DCI and poor outcome after aneurysmal SAH and Serum magnesium should be routinely monitored for both effectiveness and safety considerations.
Intravascular volume after aneurysmal subarachnoid hemorrhage
Results from the studies show that a normal volume status after SAH is not easy to achieve or to maintain and a coordinated multidisciplinary approach of the SAH patient would be appropriate.
Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: A randomized, placebo-controlled, clinical study*
The data indicate that high-dose intravenous magnesium can reduce cerebral ischemic events after aneurysmal subarachnoid hemorrhage by attenuating vasospasm and increasing the isChemic tolerance during critical hypoperfusion.
Magnesium sulfate for subarachnoid hemorrhage: a piece of the mosaic.
The results showed no significant benefit of magnesium sulfate infusion over placebo, however, the study misses considering some important characteristics and describes only 1 case of hypocalcemia.
Alterations of Mg2+ After Hemorrhagic Shock
Hemorrhagic shock induced an increase in both blood-free Mg2+ and tMg, resulted from Mg 2+ efflux from metabolic damaged cell with acidosis and ATP depletion.
Aneurysmal subarachnoid hemorrhage.
In a study from 1950 [1] it was concluded that 60% of patients with subarachnoid hemorrhage (SAH) soon or later die from the lesion, while 20% become permanently disabled and only 20% have a chance
Respone to Letter by Keller and Muroi
The design of intravenous magnesium sulfate for aneurysmal subarachnoid hemorrhage involved adding prophylactic hypermagnesemic treatment and the excitement in improvement of clinical outcome brought by specialized neurocritical care in recent years.
Nutrition and Traumatic Brain Injury: Improving Acute and Subacute Health Outcomes in Military Personnel
The potential role of nutrition in the treatment of and resilience against TBI is examined by the IOM at the request of the Department of Defense.


Magnesium Sulfate in Aneurysmal Subarachnoid Hemorrhage A Randomized Controlled Trial
Magnesium sulfate therapy reduced the risk of delayed cerebral ischemia (DCI) in patients with aneurysmal SAH by 34% and the secondary outcome measures “poor outcome” and “excellent outcome’ and the “intention-to-treat” principle were used.
Potentials of magnesium treatment in subarachnoid haemorrhage.
The neuroprotective potency of magnesium in SAH is discussed by describing the pathophysiology of ischaemia after SAH and the many ways magnesium may interfere with this.
Hypocalcemia: a pervasive metabolic abnormality in the critically ill.
It is concluded that hypocalcemia is extremely common in hospitalized patients (up to 88%) and correlates with severity of illness, but not with a specific illness per se.
Hypocalcemia in critically ill patients.
It is concluded that hypocalcemia is a frequent finding in critically ill patients; determining ionized Ca++ levels is useful because many ICU patients have alterations in both arterial pH and serum albumin levels; and hypocalcemic patients do less well clinically than normocalcepatientsmic patients.
Hypermagnesemia and hypocalcemia as predictors of high mortality in critically ill pediatric patients.
Serious hypocalcemia and hyper-magnesemia were both associated with poor outcome as measured by either survival or length of ICU stay, and ionized Ca levels could not be predicted from total Ca measurement either alone or in combination with serum albumin and pH.
Dose evaluation for long‐term magnesium treatment in aneurysmal subarachnoid haemorrhage
Magnesium is a neuroprotective agent that might prevent or reverse delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage (SAH) and this treatment regime resulted in target serum magnesium levels of 1·0–2·0 mmol/L.
Subarachnoid haemorrhage
Endovascular obliteration by means of platinum spirals (coiling) is the preferred mode of treatment, but some patients require a direct neurosurgical approach (clipping).
Acute hydrocephalus after aneurysmal subarachnoid hemorrhage.
Hydrocephalus, defined as a bicaudate index above the 95th percentile for age, was found in 34 (20%) of 174 prospectively studied patients with subarachnoid hemorrhage (SAH) who survived the first 24
Calcium Antagonists in Aneurysmal Subarachnoid Hemorrhage
To determine the effectiveness of calcium antagonists for improving outcome in patients with aneurysmal SAH, the Cochrane Stroke Group Trials Register was searched, two Russian journals were searched, and trialists were contacted.
Grading the amount of blood on computed tomograms after subarachnoid hemorrhage.
This work describes its own method, applied in previous studies, in which the amounts of blood in 10 basal cisterns and fissures and in four ventricles are graded separately, andSummed scores for extravasated blood are suitable as a baseline variable in follow-up studies of patients with subarachnoid hemorrhage.